235 related articles for article (PubMed ID: 9747881)
1. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ
Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881
[TBL] [Abstract][Full Text] [Related]
2. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
[TBL] [Abstract][Full Text] [Related]
3. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
[TBL] [Abstract][Full Text] [Related]
5. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
6. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
8. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.
Johnson BE; Brennan JF; Ihde DC; Gazdar AF
J Natl Cancer Inst Monogr; 1992; (13):39-43. PubMed ID: 1327035
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
11. Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
Ibson JM; Waters JJ; Twentyman PR; Bleehen NM; Rabbitts PH
J Cell Biochem; 1987 Apr; 33(4):267-88. PubMed ID: 3034934
[TBL] [Abstract][Full Text] [Related]
12. Genome analysis of small cell lung cancer (SCLC) and clinical significance.
Buys CH; Osinga J; van der Veen AY; Mooibroek H; van der Hout AH; de Leij L; Postmus PE; Carritt B
Eur J Respir Dis Suppl; 1987; 149():29-36. PubMed ID: 3034645
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
14. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
15. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
16. Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.
Joos S; Haluska FG; Falk MH; Henglein B; Hameister H; Croce CM; Bornkamm GW
Cancer Res; 1992 Dec; 52(23):6547-52. PubMed ID: 1330296
[TBL] [Abstract][Full Text] [Related]
17. Comparison of amplified and unamplified c-myc gene structure and expression in human small cell lung carcinoma cell lines.
Seifter EJ; Sausville EA; Battey J
Cancer Res; 1986 Apr; 46(4 Pt 2):2050-5. PubMed ID: 3004717
[TBL] [Abstract][Full Text] [Related]
18. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
Ibson JM; Rabbitts PH
Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
[TBL] [Abstract][Full Text] [Related]
20. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
